Background

Dr. Eugene Cooper, also known as Gene, Ph.D. serves as Vice President of Formulation at QR Pharma, Inc. Dr. Cooper served as Executive Vice President of SoluBest Ltd. He served as Vice President, R&D at Sterling Winthrop, Alcon, Proctor & Gamble. Dr. Cooper served as Vice President of R&D, Executive Vice President and Chief Technical Officer Research & Development at Quadrant Drug Delivery Limited (formerly, Elan Corp. and Elan Drug Delivery). He was the Head of Research ... and Development for poorly water-soluble formulation technology, including injectable, topical, and oral (liquids, modified-release, immediate-release, and fast-melt) dosage forms. He joined Elan in 1998 through the acquisition of NanoSystems LLC, where he founded and served as Chief Technical Officer and Vice President, Research and Development. He served as Executive Director of Pharmaceutical Sciences at Sterling Winthrop: Pharmaceutical Research Division. He additionally held positions at Procter & Gamble as a Section Head and at Alcon as Senior Director of Pharmaceutical Sciences and Drug Delivery. Dr. Cooper has been Member of the Scientific Advisory Board of iCeutica Inc. since June 20, 2005. Dr. Cooper won a National Science Foundation Postdoctoral Fellowship in Chemistry. He is the Author of numerous research articles and patents. He is a recipient of the top prize in Pharmaceutical Sciences, The Ebert Prize, and, in 1993, received the President’s Award for the most significant contribution to all of Sterling Winthrop; the invention of NanoCrystal® technology. He studied PhD in theoretical physical chemistry from Iowa State University. His undergraduate training was in Mathematics and Physics. He has attended the Harvard Business School Program for Management Development.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.